Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | SECT STUDIES HOST IMMUNE PONSE | address | 163644 | 2% | 28% | 8 |
2 | CATIONIC MULTILAMELLAR LIPOSOMES | authKW | 148313 | 0% | 100% | 2 |
3 | GENE IMMUNE MED | address | 142602 | 1% | 38% | 5 |
4 | CANC BIOL 173 | address | 125288 | 2% | 24% | 7 |
5 | MOL NEUROSURG | address | 82426 | 3% | 9% | 13 |
6 | ADENOVIRUS ENCODING IFN BETA | authKW | 74156 | 0% | 100% | 1 |
7 | ALLEGHENY SINGER HUMAN ONCOL | address | 74156 | 0% | 100% | 1 |
8 | ANTI ENDOTHELIAL TREATMENT | authKW | 74156 | 0% | 100% | 1 |
9 | ANTI GLUCOCORTICOID INDUCED TNF RECEPTOR ANTIBODY | authKW | 74156 | 0% | 100% | 1 |
10 | CLIN INVEST BIOTHER IE CIC BT 511 | address | 74156 | 0% | 100% | 1 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 3659 | 48% | 0% | 205 |
2 | Medicine, Research & Experimental | 692 | 16% | 0% | 68 |
3 | Immunology | 577 | 19% | 0% | 80 |
4 | Cell Biology | 161 | 12% | 0% | 50 |
5 | Biotechnology & Applied Microbiology | 145 | 9% | 0% | 39 |
6 | Genetics & Heredity | 135 | 9% | 0% | 37 |
7 | Biochemistry & Molecular Biology | 102 | 17% | 0% | 72 |
8 | Pathology | 52 | 4% | 0% | 16 |
9 | Virology | 13 | 2% | 0% | 8 |
10 | Dermatology | 9 | 2% | 0% | 7 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | SECT STUDIES HOST IMMUNE PONSE | 163644 | 2% | 28% | 8 |
2 | GENE IMMUNE MED | 142602 | 1% | 38% | 5 |
3 | CANC BIOL 173 | 125288 | 2% | 24% | 7 |
4 | MOL NEUROSURG | 82426 | 3% | 9% | 13 |
5 | ALLEGHENY SINGER HUMAN ONCOL | 74156 | 0% | 100% | 1 |
6 | CLIN INVEST BIOTHER IE CIC BT 511 | 74156 | 0% | 100% | 1 |
7 | HLTH PROMOT HUMAN BEHAVIOUR | 74156 | 0% | 100% | 1 |
8 | INNOVAT CANC THER Y CENTURY 21COE PROGR | 74156 | 0% | 100% | 1 |
9 | IST MED NUCL MOL | 74156 | 0% | 100% | 1 |
10 | SKIN MELANOMA UNIT | 74156 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF INTERFERON AND CYTOKINE RESEARCH | 20216 | 6% | 1% | 25 |
2 | CANCER GENE THERAPY | 5444 | 3% | 1% | 12 |
3 | JOURNAL OF INTERFERON RESEARCH | 4877 | 2% | 1% | 8 |
4 | INTERNATIONAL JOURNAL OF CANCER | 3452 | 7% | 0% | 31 |
5 | JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS | 2576 | 2% | 0% | 7 |
6 | JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION | 2347 | 2% | 0% | 7 |
7 | JAPANESE JOURNAL OF CANCER RESEARCH | 1682 | 2% | 0% | 9 |
8 | CLINICAL CANCER RESEARCH | 1549 | 4% | 0% | 18 |
9 | CYTOKINE & GROWTH FACTOR REVIEWS | 1405 | 1% | 0% | 4 |
10 | HUMAN GENE THERAPY | 1391 | 2% | 0% | 8 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |